|
SASH1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.362800E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.497680E-02 |
| Normal-vs-Stage2 |
4.01199999999768E-05 |
| Normal-vs-Stage3 |
1.58856999999957E-05 |
| Normal-vs-Stage4 |
5.52519999752477E-08 |
| Stage1-vs-Stage2 |
7.184700E-03 |
| Stage1-vs-Stage3 |
2.204000E-04 |
| Stage1-vs-Stage4 |
1.12699999998966E-07 |
| Stage2-vs-Stage3 |
8.060600E-01 |
| Stage2-vs-Stage4 |
2.097400E-01 |
| Stage3-vs-Stage4 |
6.844300E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.173910E-04 |
| Normal-vs-AfricanAmerican |
8.940200E-03 |
| Normal-vs-Asian |
2.306200E-01 |
| Caucasian-vs-AfricanAmerican |
6.008400E-01 |
| Caucasian-vs-Asian |
8.575200E-01 |
| AfricanAmerican-vs-Asian |
9.807600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.028300E-04 |
| Normal-vs-Female |
5.784900E-04 |
| Male-vs-Female |
5.008000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.898000E-02 |
| Normal-vs-Age(41-60Yrs) |
2.575200E-03 |
| Normal-vs-Age(61-80Yrs) |
1.89361999999305E-05 |
| Normal-vs-Age(81-100Yrs) |
4.141200E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.315200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.534800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.238400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.379530E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.505170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.675600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.473410E-01 |
| Normal-vs-Grade 2 |
1.597520E-02 |
| Normal-vs-Grade 3 |
2.83059999994784E-06 |
| Normal-vs-Grade 4 |
1.11689999471309E-08 |
| Grade 1-vs-Grade 2 |
8.579300E-04 |
| Grade 1-vs-Grade 3 |
1.597760E-03 |
| Grade 1-vs-Grade 4 |
2.810700E-04 |
| Grade 2-vs-Grade 3 |
2.28349999999988E-05 |
| Grade 2-vs-Grade 4 |
1.53689999615736E-08 |
| Grade 3-vs-Grade 4 |
1.306480E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.267900E-02 |
| Normal-vs-ccB subtype |
1.45480000002252E-06 |
| ccA subtype-vs-ccB subtype |
1.37210000028531E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.86310000000112E-05 |
| Normal-vs-N1 |
3.50279999999925E-05 |
| N0-vs-N1 |
6.986100E-02 |
|
|
